Topics

Assessment of Dyslipidemic Patients' Knowledge, Quality of Life, and Adherence

2020-03-27 03:25:31 | BioPortfolio

Summary

A randomized, parallel two-arm interventional study, the patients were divided into 1:1 ratio, in which both groups offered optimal pharmacological therapy also one group (interventional) offered predesign pharmaceutical care plan aimed to improved patients knowledge, adherence, satisfaction, and quality of life, while the other group (non-interventional) received conventional pharmaceutical care plan.

Study Design

Conditions

Dyslipidemias

Intervention

Pharmaceutical care plan

Location

Al-Rasheed University College
Baghdad
AL-Adhmia
Iraq
12221

Status

Completed

Source

Al-Rasheed University College

Results (where available)

View Results

Links

Published on BioPortfolio: 2020-03-27T03:25:31-0400

Clinical Trials [514 Associated Clinical Trials listed on BioPortfolio]

Establishment of a Personalized Pharmaceutical Plan in Renal or Hepatic Transplant Patients: Randomized Clustered Stepped-wedge Trial.

The main objective of the study is to evaluate the impact of the Personalized Pharmaceutical Plan on the therapeutic adherence to immunosuppressive treatments one year after liver or kidne...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

PubMed Articles [12793 Associated PubMed Articles listed on BioPortfolio]

Strategies to ensure that all patients have a personalised nursing care plan.

Emeritus Professor , from the University of Southampton, discusses processes for ensuring that all patients have an up-to-date personalised care plan that details all their care needs during admission...

Developing and introducing a post birth care plan (PBCP): An action research project.

There is ongoing poor evaluation of post-birth care and an urgent need to improve women's satisfaction. To develop and evaluate an acceptable and useable post-birth care plan template through collabor...

Development of the Recommended Summary Plan for Emergency Care and Treatment (ReSPECT).

Do-not-attempt-cardiopulmonary-resuscitation (DNACPR) practice has been shown to be variable and sub-optimal. This paper describes the development of the Recommended Summary Plan for Emergency Care an...

The effect of a pharmaceutical transitional care program on rehospitalisations in internal medicine patients: an interrupted-time-series study.

Medication errors at transition of care can adversely affect patient safety. The objective of this study is to determine the effect of a transitional pharmaceutical care program on unplanned rehospita...

Premedical Student Exposure to Pharmaceutical Marketing: Too Much, Too Soon?

Direct pharmaceutical marketing to physicians by pharmaceutical representatives is effective in changing behavior of health care providers, resulting in less evidence-based prescribing. Although much ...

Medical and Biotech [MESH] Definitions

A health care system which combines physicians, hospitals, and other medical services with a health plan to provide the complete spectrum of medical care for its customers. In a fully integrated system, the three key elements - physicians, hospital, and health plan membership - are in balance in terms of matching medical resources with the needs of purchasers and patients. (Coddington et al., Integrated Health Care: Reorganizing the Physician, Hospital and Health Plan Relationship, 1994, p7)

Economic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. (From J Res Pharm Econ 1989;1(1); PharmacoEcon 1992;1(1))

An Act prohibiting a health plan from establishing lifetime limits or annual limits on the dollar value of benefits for any participant or beneficiary after January 1, 2014. It permits a restricted annual limit for plan years beginning prior to January 1, 2014. It provides that a health plan shall not be prevented from placing annual or lifetime per-beneficiary limits on covered benefits. The Act sets up a new competitive health insurance market giving tens of millions of Americans the same choices of insurance that members of Congress will have. It aims to bring greater accountability to health care and to control cost of health insurance premiums.

Summaries that serve as the primary documents communicating a patient's care plan to the post-hospital care team.

Organization of medical and nursing care according to the degree of illness and care requirements in the hospital. The elements are intensive care, intermediate care, self-care, long-term care, and organized home care.

More From BioPortfolio on "Assessment of Dyslipidemic Patients' Knowledge, Quality of Life, and Adherence"

Quick Search

Searches Linking to this Trial